Response to Letter Regarding Article, “Cardiac outcomes after ischemic stroke or transient ischemic attack: effects of pioglitazone in patients with insulin resistance without diabetes mellitus”

Ítems similars

• Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
  per: Kernan, W.N., et al.
  Publicat: (2016)
• Pioglitazone for Secondary Prevention after Ischemic Stroke and Transient Ischemic Attack: Rationale and Design of the Insulin Resistance Intervention after Stroke (IRIS) Trial
  per: Viscoli, Catherine M., et al.
  Publicat: (2014)
• Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction
  per: Kernan, Walter N., et al.
  Publicat: (2017)
• A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack
  per: Xu, Jin, et al.
  Publicat: (2016)
• Cardiac Outcomes after Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance without Diabetes
  per: Young, Lawrence H., et al.
  Publicat: (2017)